Phyllis Chan

842 citations
39 papers · 600 · h-index 16

Impact in

Papers in

    • Cancer Immunotherapy and Biomarkers 9
    • CAR-T cell therapy research 5
    • Colorectal Cancer Treatments and Studies 4
    • Biosimilars and Bioanalytical Methods 5

Phyllis Chan

37 papers receiving 578 citations

Peers

Phyllis Chan
Comparison fields: 5 of 80
  • Oncology 139
  • Hepatology 37
  • Gastroenterology 24
  • Statistics and Probability 39
  • Psychiatry and Mental health 54
Replace Afsaneh Shirani with:
Afsaneh Shirani United States
David Phillippo United Kingdom
David Ellenberger Germany
G McCormack United States
Stefan Englert Germany
Daniel Wachtlin Germany
Sue Ashley United Kingdom
Gillian Gresham United States
Markus C. Elze United Kingdom
Titilola Falasinnu United States
Phyllis Chan relative to Afsaneh Shirani United States Afsaneh Shirani's profile →
Citations per field
00.5×
Afsaneh Shirani · 1×
Citations per year

Countries citing papers authored by Phyllis Chan

Since Specialization
Citations

This map shows the geographic impact of Phyllis Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phyllis Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phyllis Chan more than expected).

Fields of papers citing papers by Phyllis Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phyllis Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phyllis Chan. The network helps show where Phyllis Chan may publish in the future.

Co-authors

The 25 scholars most cited alongside Phyllis Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Phyllis Chan Line = papers co-authored together Phyllis Chan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201795
2 202143
3 202237
4 198337
5 201531
6 202330
7 202127
8 202125
9 201724
10 197722
11 202021
12 202117
13 202016
14 202116
15 201715
16 202115
17 202313
18 201712
19 202012
20 201711

About Phyllis Chan

Phyllis Chan is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Hepatology and Pulmonary and Respiratory Medicine, having authored 39 papers that have together received 600 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), CAR-T cell therapy research (5 papers), Biosimilars and Bioanalytical Methods (5 papers), Hepatitis C virus research (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Attention Deficit Hyperactivity Disorder (4 papers) and Hepatitis B Virus Studies (3 papers). The work is most often cited by research in Oncology (139 citations), Hepatology (37 citations), Gastroenterology (24 citations), Statistics and Probability (39 citations) and Psychiatry and Mental health (54 citations). Phyllis Chan has collaborated with scholars based in United States, France and China. Frequent co-authors include René Bruno, Ian Chi Kei Wong, Patrick Ip, Esther W. Chan, Benjamin Wu, Xuyang Song, David Coghill, Emily Simonoff, Kenneth K. C. Man and Miriam Sturkenboom. Their work appears in journals such as CPT Pharmacometrics & Systems Pharmacology, Cancer Chemotherapy and Pharmacology, The Journal of Clinical Pharmacology, Pharmaceutical Research and Clinical and Translational Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact